Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Cash Flow Quality Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Cash Flow Quality Index of 10.86x as of June 2023. Operating cash flow of $118.87 Million exceeds net income of $10.94 Million, indicating high earnings quality where cash backs reported profits. Explore 900904 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 900904 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
Year-by-year earnings quality comparison for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B. For live market cap and the full company financial profile, see Shanghai Shenqi Pharmaceutical Investmen stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.91x | $207.79 Million | $71.39 Million | ▼ -23.0% |
| 2023 | 3.78x | $215.59 Million | $57.00 Million | ▼ -42.6% |
| 2022 | 6.59x | $319.23 Million | $48.48 Million | ▲ +148.8% |
| 2021 | 2.65x | $184.26 Million | $69.62 Million | ▲ +73.3% |
| 2019 | 1.53x | $128.28 Million | $83.97 Million | ▲ +9.1% |
| 2018 | 1.40x | $148.53 Million | $106.09 Million | ▲ +170.9% |
| 2017 | 0.52x | $66.99 Million | $129.60 Million | ▲ +16397.2% |
| 2016 | 0.00x | $570.41K | $182.06 Million | ▼ -97.7% |
| 2015 | 0.14x | $30.12 Million | $216.73 Million | — |